Please find attached Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Bombay Oxygen Investments Ltd (an NBFC/investment company) approved audited financial results for Q4 and FY ended 31st March 2025, with the statutory auditor issuing an unqualified report. Total income fell sharply to Rs. 2,090.39 lakhs (FY24: Rs. 7,221.60 lakhs) and PAT dropped to Rs. 1,750.59 lakhs (FY24: Rs. 5,760.09 lakhs), primarily due to lower fair-value gains on investments. The Board recommended a dividend of Rs. 35 per share (35%) on Rs. 100 face value, subject to shareholder approval. The 64th AGM is scheduled for 15th July 2025 via video conferencing. M/s SCP & Co. was appointed as Secretarial Auditor for 5 years, and Ms. Hema Renganathan was re-appointed as Whole-Time Director for 2 years from 1st July 2025 to 30th June 2027.
Despite the steep year-on-year decline in profits driven by mark-to-market losses on investments, the company declared a healthy 35% dividend, signaling confidence in cash flows. Q4 FY25 showed a standalone loss, but the full-year remained profitable, so shareholders should track investment portfolio performance closely.